Recombinant chimeric antibody expressed in CHO binding to human CAIX. Girentuximab is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma. https://www.creativebiolabs.net/Anti-CAIX-CA9-Therapeutic-Antibody-Rencarex-13758.htm